The soft x-ray tomography diagnostic in the stellarator Wendelstein 7-X consists of twenty pinhole cameras, up–down symmetrically arranged in a poloidal, triangular cross-section of the plasma vessel. The x-ray emissivity is measured with 16 bit amplitude resolution at 2 MHz sampling rate along 360 lines-of-sight by silicon photodiode arrays. In the recent operation campaign data acquisition (DAQ) has been working reliable for the conducted plasma pulse lengths <1 min, however the DAQ system are ready for the foreseen 30 min plasma pulse lengths of upcoming campaigns. The bandwidth of the preamplifiers is ≈200 kHz and the sensitive energy range is approximately 1–12 keV. The measurements indicate the up–down symmetric emissivity distribution in the triangular poloidal cross-section. First tomographic reconstructions of different magnetic field configurations are consistent with the theoretically calculated flux surface topology.
To improve the reliability of the ASDEX pressure gauges in the plasma vessel of the Wendelstein 7-X stellarator, nine of them were equipped with a LaB 6 crystal electron emitter for the first time. These crystal cathode pressure gauges were operated during the last campaign in 2018 (operation phase 1.2b) with only 2 A heating current for over 40 h in a magnetic field of about 2.1 T without failure. Owing to this excellent performance, we have decided to equip all pressure gauges with crystal cathodes for the next campaign of Wendelstein 7-X (operation phase 2). We report on a pretest in a superconducting magnet, show a measurement of the neutral pressure in Wendelstein 7-X, and demonstrate the long-term stability of the crystal cathode pressure gauges.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.